Endometrioid carcinoma of the ovary is the third most common epithelial tumour of the ovary, accounting for between 16% and 25% of these tumours.1 A co -existing adenocarcinoma of the endometrium has been found in 14-25% of patients.2' 3 CASE REPORT A 45-year-old female, para 2, presented to the gynaecological outpatient clinic with a two-year history of menorrhagia. There was no intermenstrual or postcoital bleeding. General examination was satisfactory apart from obesity (94 kg).
Endometrioid carcinoma of the ovary is the third most common epithelial tumour of the ovary, accounting for between 16% and 25% of these tumours.1 A co -existing adenocarcinoma of the endometrium has been found in 14-25% of patients. 2' 3 CASE REPORT A 45-year-old female, para 2, presented to the gynaecological outpatient clinic with a two-year history of menorrhagia. There was no intermenstrual or postcoital bleeding. General examination was satisfactory apart from obesity (94 kg). biopsy specimen was reviewed and confirmed as showing only adenomatous hyperplasia with some squamous metaplasia). In the uterine cervix the surface and crypt endocervical epithelium showed a combination of tubal metaplasia and adenocarcinoma in situ. This neoplastic epithelium had differentiated along endometrial lines. There was no invasive malignancy. The fallopian tubes did not show any significant abnormality and the left ovary contained a haemorrhagic corpus luteum. There were no postoperative complications and she was discharged home to start a first course of chemotherapy with cisplatin (cis-diamminedichloro-platinum).
COMMENT Ovarian epithelial neoplasms exhibit a spectrum of Mullerian differentiation which includes an endometrioid pattern. The two commonest ovarian carcinomas are serous and mucinous cystadenocarcinomas. Women with endometrioid tumours of the ovary have a relatively favourable prognosis, a five-year survival rate varying between 40% and 70%,1 2 compared with 26% for serous cystadeno carcinoma. 4 The presence of a co -existing adenocarcinoma of the endometrium with endometrioid carcinoma is a relatively common finding, occurring in 14-25% of patients2 3 and the concomitant endometrial carcinoma is not detrimental to the prognosis.5 Women with concomitant tumours were thought to present at an earlier age than expected for either ovarian or endometrial carcinoma 2,5 although this is now disputed. It has been shown in a recent study that there was no significant difference in age or menopausal status between the women who presented with an ovarian lesion only and those who presented with concomitant tumours. To our knowledge, this report is the first to describe adenocarcinoma in situ of the cervix in association with both endometrioid carcinoma of the ovary and adenocarcinoma of the endometrium. It is a very unusual case of multifocal malignant field change in the Mullerian epithelium along endometrial lines. It highlights the possibility of concurrent disease in developmentally linked but anatomically distinct sites and serves to emphasise the need for an integrated approach to gynaecological assessment in these patients.
